David McCombs and Jonathan Bowser of Haynes Boone examine the USPTO director's restoration of strict real party-in-interest ...
In this edition of The Precedent, we outline the decision in IGT v. Zygna Inc. This case affirms an obviousness finding by ...
The Federal Circuit recently vacated a summary judgment ruling of invalidity, holding that the district court erred in applying preclusive effect ...
The Federal Circuit has denied three mandamus petitions asking the court to step in and curb the recently-implemented ...
A group of 106 students from the eight North Eastern States visited the Indian Space Research Organisation (ISRO) Centre in Bengaluru ...
The U.S. Court of Appeals for the Federal Circuit on Monday heard oral argument in Micron Technology v. Longhorn IP, a test ...
Pfizer beats Q3 estimates, raises FY guidance, acquires Metsera for obesity drugs, and offers a 7% yield. Read here for an ...
Govt proposes amendments to Patent Rules 2003 introducing Code of Conduct, disciplinary procedures, and complaint mechanisms for patent ...
AI-based drug developer Recursion’s stock barely moved Wednesday, then dropped Thursday and Friday, after reporting mixed third quarter results, setting the stage for future pipeline announcements—and ...
Viatris Inc. (Nasdaq: VTRS) today reported strong third quarter 2025 financial results and updated full-year financial ...
Detailed price information for Regeneron Pharmaceuticals (REGN-Q) from The Globe and Mail including charting and trades.
QPR SOFTWARE PLC STOCK EXCHANGE RELEASE 31 October 2025, AT 9.00 AM EETQPR Software Plc Interim Report January-September 2025: The company's SaaS net sales grew by 2%. QPR ProcessAnalyzer's ...